Announcements Trials

Browse Landscape

Sponsor

Conditions

Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1

Interventions

Sorafenib 5 Nivolumab 3 lenvatinib 2 cabozantinib 2 Ipilimumab 2 ulixertinib 1 tremelimumab 1 trastuzumab biosimilar HLX02 1 trametinib 1 sapanisertib 1 sacituzumab govitecan 1 relatlimab 1 pertuzumab 1 pembrolizumab 1 palbociclib 1 osimertinib 1 omipalisib 1 larotrectinib 1 ipatasertib 1 erdafitinib 1 durvalumab 1 defactinib 1 dabrafenib 1 copanlisib 1 capivasertib 1 binimetinib 1 atezolizumab 1 adavosertib 1 X-Rays 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Carcinoma, Hepatocellular × olutasidenib × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡